Final overall survival (OS) results from the INAVO120 trial (NCT04191499) confirmed that the addition of inavolisib (Itovebi) ...

Diabetes is a leading global health and economic challenge, affecting over 800 million people worldwide, with over 80% ...

The incidence of type 2 diabetes mellitus is increasing among youths. Once-weekly treatment with dulaglutide, a glucagon-like peptide-1 receptor ... thyroid C-cell hyperplasia, or medullary ...

Now, a study of 170,000 patient records suggests there's a slightly lower risk of obesity-related cancers in U.S. adults with diabetes who took these popular medications compared to those who took ...

The use of finerenone in patients with type 2 diabetes and a wider range of ... and all authors had access to and participated in the interpretation of the analyzed data. The first and second ...

Sen. Maggie Hassan (D-N.H.) tussled with Homeland Security Secretary Kristi Noem at a committee hearing Tuesday over habeas corpus, which the administration is considering suspending as it ...

Candy is not off-limits simply because you have diabetes. “I encourage people with diabetes to remember that a diabetes diet is really just a healthier diet,” says Rainie Robinson ...

A 3‐arm analysis including the glucagon‐like peptide‐1 receptor agonist cohort was conducted. This cohort included 75 470 patients with type 2 diabetes (median age, 62.3±12.8 years; 55.79% men). The ...

You’re doing everything right to manage your type 2 diabetes. You’re watching your carb intake, exercising regularly, and following your treatment plan. You’re avoiding bad habits — such ...